LON:ADN 1724525 (ADN.L) (ADN) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get 1724525 (ADN.L) alerts: Email Address About 1724525 (ADN.L) Stock (LON:ADN) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyI’m giving you the name of this investment for freeIn this video I reveal one of the most powerful wealth secrets in American history. One that has been buried in America’s legal system for the last 150 years. But I believe this secret could also help you reclaim your dignity and freedom before it’s all taken away from you. Watch now. Get 1724525 (ADN.L) alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume3.09 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAberdeen Asset Management PLC is a United Kingdom-based asset manager. The Company operates through asset management for reporting and control purposes. The Company is managed as a single asset management business, with multiple investment strategies of equities, fixed income and property, complemented by a solutions business, which provides multi asset, alternatives and quantitative investment capabilities. These strategies are managed across a range of products, distribution channels and geographic regions. The Company holds investments in seed capital investments, investments in certain Aberdeen-managed funds to hedge deferred fund awards and other investments. The Company operates in approximately 20 countries. Its operations span across Asia Pacific, Australia, the United Kingdom, the United States, the Middle East and Europe, among others.Read More… I’m giving you the name of this investment for free (Ad)In this video I reveal one of the most powerful wealth secrets in American history. One that has been buried in America’s legal system for the last 150 years. But I believe this secret could also help you reclaim your dignity and freedom before it’s all taken away from you. Watch now. Receive ADN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 1724525 (ADN.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address ADN Stock News HeadlinesDr. Russell G. HiranoJuly 1, 2023 | health.usnews.comAdvent Technologies Holdings, Inc. (ADN)November 15, 2022 | finance.yahoo.comSee More Headlines ADN Stock Analysis - Frequently Asked Questions How do I buy shares of 1724525 (ADN.L)? Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of 1724525 (ADN.L) own? Based on aggregate information from My MarketBeat watchlists, some other companies that 1724525 (ADN.L) investors own include Babcock International Group (BAB), Bayerische Motoren Werke Aktiengesellschaft (BMW), Centrica (CNA), Lloyds Banking Group (LLOY), Barclays (BARC), The Berkeley Group (BKG) and Oshkosh (OSK). Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Optical Instrument & Lens Manufacturing Sub-IndustryElectrical Equipment Current SymbolLON:ADN CUSIPN/A CIKN/A Webwww.aberdeen-asset.com Phone+44-1224-631999FaxN/AEmployees200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (LON:ADN) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 1724525 (ADN.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share 1724525 (ADN.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.